Coincident to the June 5, 2025 annual launch of their Fortune 500, Fortune also partnered with Indiggo to measure Return On Leadership, called the ROL100. Arnold research focused on those 100 using YCharts 6/6/25 data on Dividends from 78, which hereafter are referred to as the Fortune Return on Leadership Dividend Dogs (FROLD). ReturnOnLeadership is based on four fundamental factors: Connectio...
CVS Health reportedly plans to invest $20 billion over the next 10 years to build a “tech-enabled consumer health experience” that will encompass the company, its vertically integrated businesses, and other companies, including competitors, who want to join.
My top 10 high-yield picks for June 2025 balance attractive dividend yields, strong financials, and competitive advantages to reduce risk and enhance returns. I use a rigorous four-step selection process: screening for size, yield, and valuation; assessing competitive advantages; deep valuation analysis; and ensuring industry and geographic diversification. Each company's allocation limit is de...
CVS Health Thursday sued the state of Arkansas, trying to thwart a law the healthcare company said would lead to the closure of all 23 CVS drugstores in the state.
Dividend stocks are facing many big risks. The high interest rates, trade war, and AI revolution could lead to many dividend cuts. I discuss what this all means for dividend investors.
Walgreens confirmed its only buying prescription files and not brick and mortar stores among the pharmacy assets being sold across the U.S. by Rite Aid.
A federal bankruptcy court has approved the sale of pharmacy assets from more than 1,000 Rite Aid stores to CVS Health, Walgreens as well as grocery store chains including Kroger and Albertsons.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.